Yanru Qin

Yanru Qin

Auto-generated profile, based on publicly available information

Yanru Qin

Medical Oncology Department, Chinese Academy of Medical Sciences - National Cancer Center, Cancer Hospital, Beijing, China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2021 in Annals of Oncology
Verified
Journal Article
Closed access
YSY-K. Shi
Y-K. Shi
YQY. Qin
Y. Qin
WZW. Zhang
W. Zhang
XWX. Wang
X. Wang
HLHongmei Liu
Hongmei Liu
RZRenbin Zhao
Renbin Zhao

12 August 2020 in Research Square
Verified
Preprint
Open access
PDF file
CLChenxu Liu
Chenxu Liu
YQYanru Qin
Yanru Qin
ZCZhiwei Chang
Zhiwei Chang
WWWenjia Wang
Wenjia Wang
LDLin Dong
Lin Dong
Objectives The aim of this study is to analyze the clinical and pathological features of HAS and investigate the factors affecting prognosis.Methods From January 2014 to May 2020, 31 patients were diagnosed as HAS in in the First Affiliated Hospital of Zhengzhou University. The clinicopathologic features and the relevant prognosis of these patients were analyzed.Results Of the 31 patients, 23 were male, with a median age of 62 years. And among the 31 patients, 22 patients underwent a radical gastrectomy and a D2 lymph node dissection. During the follow up period, 18 patients died of the disease. The median OS (mOS) was 28 months. The 1-year survival rate was 55%, the 3-year survival rate was 47%, and the 5-year survival rate was 34%. An elevated CA125 level, distant metastasis, and radical surgery were associated with the prognosis of HAS, and distant metastasis is an independent prognostic risk factor for survival. Conclusion HAS had a poor prognosis because of its frequent vascular involvement, and lymph node and liver metastasis. Aggressive multimodal treatment comprising radical gastrectomy and adjuvant chemotherapy is warranted.This article describes the Clinicopathological of Hepatoid Adenocarcinoma of the Stomach and through survival analysis, the factors affecting the patient’s prognosis were studied.